Abeona Therapeutics Inc.
ABEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $400 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $488 | $100 | $0 | $776 |
| Gross Profit | -$488 | $300 | $0 | -$776 |
| % Margin | – | 75% | – | – |
| R&D Expenses | $4,216 | $5,943 | $9,941 | $8,994 |
| G&A Expenses | $0 | $17,149 | $9,786 | $0 |
| SG&A Expenses | $19,314 | $17,149 | $9,786 | $6,902 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $23,530 | $23,092 | $19,727 | $15,896 |
| Operating Income | -$24,018 | -$22,792 | -$19,727 | -$16,672 |
| % Margin | – | -5,698% | – | – |
| Other Income/Exp. Net | $3,660 | $147,137 | $7,698 | $7,379 |
| Pre-Tax Income | -$20,358 | $124,345 | -$12,029 | -$9,293 |
| Tax Expense | -$15,197 | $15,512 | $0 | $0 |
| Net Income | -$5,161 | $108,833 | -$12,029 | -$9,293 |
| % Margin | – | 27,208.3% | – | – |
| EPS | -0.1 | 2.07 | -0.24 | -0.23 |
| % Growth | -104.8% | 962.5% | -4.3% | – |
| EPS Diluted | -0.1 | 1.71 | -0.24 | -0.23 |
| Weighted Avg Shares Out | 54,243 | 52,525 | 49,779 | 41,048 |
| Weighted Avg Shares Out Dil | 54,243 | 66,641 | 49,779 | 41,048 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,672 | $1,027 | $1,310 | $1,023 |
| Interest Expense | $901 | $957 | $998 | $1,082 |
| Depreciation & Amortization | $888 | $768 | $815 | $776 |
| EBITDA | -$18,569 | $126,070 | -$10,216 | -$7,437 |
| % Margin | – | 31,517.5% | – | – |